Back
OptimizeRx 10K Form
Sell
46
OPRX
OptimizeRx
Last Price:
4.43
Seasonality Move:
4.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-05 | 10Q | OPRX/OptimizeRx Quarterly |
2020-05-06 | 10Q | OPRX/OptimizeRx Quarterly |
2020-03-26 | 10K | OPRX/OptimizeRx Annual |
2019-11-05 | 10Q | OPRX/OptimizeRx Quarterly |
2019-08-07 | 10Q | OPRX/OptimizeRx Quarterly |
2019-05-08 | 10Q | OPRX/OptimizeRx Quarterly |
Receive OPRX News And Ratings
See the #1 stock for the next 7 days that we like better than OPRX
OPRX Financial Statistics
Sales & Book Value
Annual Sales: | $71.52M |
---|---|
Cash Flow: | $1.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.25 |
Price / Book: | 0.68 |
Profitability
EPS (TTM): | -1.34000 |
---|---|
Net Income (TTM): | $-24.17M |
Gross Margin: | $42.9M |
Return on Equity: | -20.12% |
Return on Assets: | -14.71% |
OptimizeRx Earnings Forecast
Key OptimizeRx Financial Ratios
- The Gross Profit Margin over the past 17 years for OPRX is 59.98%.
- The Selling, General & Administrative Expenses for OPRX have been equal to 81.12% of Gross Profit Margin.
- The Research & Development expenses have been 2.49% of Revenue.
- The Interest Expense is -8.28% of Operating Income.
- The Net Earning history of OPRX is -24.56% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 7 years.
OptimizeRx Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | OPRX |
CUSIP: | 68401U |
Website: | optimizerx.com |
Debt
Debt-to-Equity Ratio: | 0.31 |
---|---|
Current Ratio: | 3.23 |
Quick Ratio: | 2.93 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 11.71 |
OPRX Technical Analysis vs Fundamental Analysis
Sell
46
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy or a Sell?
-
OptimizeRx stock is rated a Sell
The current OptimizeRx [OPRX] share price is $4.42. The Score for OPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.